Proposed Collection; Comment Request: Solar Cell: A Mobile UV Manager for Smart Phones (NCI), 2734-2735 [2012-872]
Download as PDF
<![CDATA[
2734
Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to (202) 395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: January 12, 2012.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2012–954 Filed 1–18–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Health Information Technology
Implementation
Health Resources and Services
Administration, HHS.
ACTION: Notice of Noncompetitive
Replacement Award to Tennessee
Primary Care Association, Brentwood,
Tennessee.
AGENCY:
The Health Resources and
Services Administration (HRSA) will be
transferring the American Recovery and
Reinvestment Act (ARRA) (section 330
of the Public Health Service Act) Health
Information Technology
Implementation for Health Center
Controlled Networks (HCCN) funds
originally awarded to Community
Health Network, Inc. (CHN), to the
Tennessee Primary Care Association
(TPCA) to ensure the implementation of
a Health Center Controlled Network in
the State of Tennessee.
SUPPLEMENTARY INFORMATION:
Former Grantee of Record:
Community Health Network, Inc.
Original Period of Grant Support:
June 1, 2010, to May 31, 2012.
Replacement Awardee: Tennessee
Primary Care Association.
Amount of Replacement Award:
$1,807,399.60.
Period of Replacement Award: The
period of support for the replacement
award is December 1, 2011, to May 31,
2012.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
Authority: Section 330 of the Public Health
Service Act, 42 U.S.C. 245b.
CFDA Number: 93.703
Justification for the Exception to
Competition
The former grantee (CHN)
relinquished the grant and its
VerDate Mar<15>2010
16:21 Jan 18, 2012
Jkt 226001
responsibilities due to financial
difficulties as well as management and
legal concerns. TPCA has been a HRSA
funded Primary Care Association since
1985 and is a well established
organization with sound fiscal and
grants management operations.
In the effort to preserve the
opportunity to advance information
technology resources of the Tennessee’s
medically underserved communities,
TPCA has demonstrated the capacity to
fulfill the expectations of the original
grant award and has collaborated with
CHN’s Board of Directors to plan for a
smooth transition of the grant.
The transfer of these funds will
ensure full implementation of the grant
which will greatly advance the State of
Tennessee’s continuity of care and have
a positive impact on population health.
It will also help the participating health
centers to meet requirements for
Meaningful Use and Patient Centered
Medical Home programs by the Centers
for Medicare and Medicaid Services
(CMS), the National Committee for
Quality Assurance (NCQA) and/or the
Joint Commission.
The implementation of a Health
Center Controlled Network would assist
with the advancement and effective use
of Health Information Technology.
These advancements will result in
measurable improvements in patient
outcomes and reductions of health
disparities for underserved communities
in the State of Tennessee. As a result, in
order to ensure a timely implementation
of a Health Center Controlled Network
in the State of Tennessee as originally
awarded, this replacement award will
not be competed.
FOR FURTHER INFORMATION CONTACT: Ms.
Mayra Nicolas via phone at (301) 594–
4294 or via email at mnicolas@hrsa.gov.
Dated: January 10, 2012.
Mary K. Wakefield,
Administrator.
[FR Doc. 2012–964 Filed 1–18–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Advisory Council on Migrant
Health; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: National Advisory Council on
Migrant Health.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Dates and Times: February 7, 2012, 8:30
a.m. to 5 p.m.; February 8, 2012, 8:30 a.m.
to 5 p.m.
Place: Crystal Gateway Marriott Hotel,
1700 Jefferson Davis Highway, Arlington,
Virginia 22202. Telephone: (703) 920–3230.
Fax: (703) 271–5212.
Status: The meeting will be open to the
public.
Purpose: The purpose of the meeting is to
discuss services and issues related to the
health of migrant and seasonal farmworkers
and their families and to formulate
recommendations for the Secretary of Health
and Human Services.
Agenda: The agenda includes an overview
of the Council’s general business activities.
The Council will also hear presentations
from experts on farmworker issues, including
the status of farmworker health at the local
and national levels.
Agenda items are subject to change as
priorities indicate.
FOR FURTHER INFORMATION CONTACT:
Gladys Cate, Office of Special
Population Health, Bureau of Primary
Health Care, Health Resources and
Services Administration, 5600 Fishers
Lane, Room 15–62, Rockville, Maryland
20857; telephone (301) 594–0367.
Dated: January 12, 2012.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2012–959 Filed 1–18–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request: Solar Cell: A Mobile UV
Manager for Smart Phones (NCI)
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI), the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: Solar Cell:
A Mobile UV Manager for Smart Phones
(NCI). Type of Information Collection
Request: New. Need and Use of
Information Collection: The overall goal
of the study is to design a smart phone
application, Solar Cell, which uses
smart phone technology to aid users in
protecting their skin from damaging
ultraviolet radiation (UV) in sunlight, a
primary cause of skin cancer. The
purpose of this part of the study is to
produce, deploy, and evaluate the
SUMMARY:
E:\FR\FM\19JAN1.SGM
19JAN1
Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices
effectiveness of a state-of-the-art
software application for smart phones
(i.e., mobile application), ‘‘Solar Cell.’’
This software application supports
decision-making related to sun
protection and exposure by Americans
to reduce the risk of developing skin
cancer attributable to chronic and severe
UV exposure and developing other
cancers attributable to vitamin D
deficiency. The Solar Cell mobile smart
phone application combines personal
and behavior data with geo-spatial data
(i.e., UV Index forecast, time, and
location) and delivers actionable sun
protection advice to reduce risk of skin
cancer. Frequency of Response: Once.
Affected Public: Individuals. Type of
2735
Respondents: Adults (18 and over) from
the U.S. population who own Android
smart phones. The annual reporting
burden is estimated at 673 (see Table
below). There are no Capital Costs,
Operating Costs, and/or Maintenance
Costs to report.
A.12–1—ESTIMATES OF ANNUAL BURDEN HOURS
Number of
respondents
Type of respondents
Instrument
Adults ....................................
Screener (Appendix G) .........
Pre-test (Appendix A) ...........
Post-test (Appendix B) .........
1,875
245
184
Totals .............................
To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Patricia Weber,
DrPH, Program Director, NCI/NIH, SBIR
Development Center, 6116 Executive
Blvd., Suite 402, Rockville, MD 20852
or call non-toll-free number (301) 594–
8106 or email your request, including
your address to: weberpa@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
mstockstill on DSK4VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Dated: January 11, 2012.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2012–872 Filed 1–18–12; 8:45 am]
BILLING CODE 4140–01–P
16:21 Jan 18, 2012
1
1
1
15/60 (0.25)
20/60 (0.33)
40/60 (0.66)
2,304
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
VerDate Mar<15>2010
Average time per
response
(minutes/hour)
Frequency of
response
Jkt 226001
National Institutes of Health
National Human Genome Research
Institute; Notice of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Advisory Council for Human Genome
Research.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: February 13–14, 2012.
Open: February 13, 2012, 8:30 a.m. to
3 p.m.
Agenda: To discuss matters of program
relevance.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conference
Room, Rockville, MD 20892.
Frm 00052
Fmt 4703
Sfmt 4703
469
82
123
673
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Annual burden
hours
Closed: February 13, 2012, 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fishers Lane Terrace Level Conference Room,
Rockville, MD 20892.
Closed: February 14, 2012, 8:30 a.m. to
5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals National
Institutes of Health, 5635 Fishers Lane,
Terrace Level Conference Room, Rockville,
MD 20892.
Contact Person: Mark S. Guyer, Ph.D.,
Director for Extramural Research National
Human Genome Research Institute, 5635
Fishers Lane, Suite 4076, MSC 9305,
Bethesda, MD 20892, (301) 496–7531
guyerm@mail.nih.gov.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: May 21–22, 2012.
Open: May 21, 2012, 8:30 a.m. to 3 p.m.
Agenda: To discuss matters of program
relevance.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conference
Room, Rockville, MD 20892.
Closed: May 21, 2012, 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conference
Room, Rockville, MD 20892.
Closed:May 22, 2012, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fishers Lane, Terrace Level Conference
Room, Rockville, MD 20892.
Contact Person: Mark S. Guyer, Ph.D.,
Director for Extramural Research, National
Human Genome Research Institute, 5635
Fishers Lane, Suite 4076, MSC 9305,
Bethesda, MD 20892, (301) 496–7531,
guyerm@mail.nih.gov.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: September 10–11, 2012.
Open: September 10, 2012, 8:30 a.m. to
3 p.m.
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 77, Number 12 (Thursday, January 19, 2012)]
[Notices]
[Pages 2734-2735]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-872]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request: Solar Cell: A Mobile UV
Manager for Smart Phones (NCI)
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Cancer Institute
(NCI), the National Institutes of Health (NIH) will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Proposed Collection: Title: Solar Cell: A Mobile UV Manager for
Smart Phones (NCI). Type of Information Collection Request: New. Need
and Use of Information Collection: The overall goal of the study is to
design a smart phone application, Solar Cell, which uses smart phone
technology to aid users in protecting their skin from damaging
ultraviolet radiation (UV) in sunlight, a primary cause of skin cancer.
The purpose of this part of the study is to produce, deploy, and
evaluate the
[[Page 2735]]
effectiveness of a state-of-the-art software application for smart
phones (i.e., mobile application), ``Solar Cell.'' This software
application supports decision-making related to sun protection and
exposure by Americans to reduce the risk of developing skin cancer
attributable to chronic and severe UV exposure and developing other
cancers attributable to vitamin D deficiency. The Solar Cell mobile
smart phone application combines personal and behavior data with geo-
spatial data (i.e., UV Index forecast, time, and location) and delivers
actionable sun protection advice to reduce risk of skin cancer.
Frequency of Response: Once. Affected Public: Individuals. Type of
Respondents: Adults (18 and over) from the U.S. population who own
Android smart phones. The annual reporting burden is estimated at 673
(see Table below). There are no Capital Costs, Operating Costs, and/or
Maintenance Costs to report.
A.12-1--Estimates of Annual Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average time per
Type of respondents Instrument Number of Frequency of response Annual burden
respondents response (minutes/hour) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Adults...................................... Screener (Appendix G)......... 1,875 1 15/60 (0.25) 469
Pre-test (Appendix A)......... 245 1 20/60 (0.33) 82
Post-test (Appendix B)........ 184 1 40/60 (0.66) 123
���������������������������������������������
Totals.................................. 2,304 673
--------------------------------------------------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Enhance the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Patricia Weber, DrPH, Program Director, NCI/NIH,
SBIR Development Center, 6116 Executive Blvd., Suite 402, Rockville, MD
20852 or call non-toll-free number (301) 594-8106 or email your
request, including your address to: weberpa@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Dated: January 11, 2012.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2012-872 Filed 1-18-12; 8:45 am]
BILLING CODE 4140-01-P
